Wesley Grubbs founded Pitch Interactive, with more than 20 years of experience in the interactive industry. He is in charge of technical and creative direction and managing all crucial aspects that define the project scope, client expectations, deliverables and storytelling. He holds a Master’s degree in Information Systems and a Bachelor’s degree in International Economics from the University of Arkansas.
Wesley Grubbs
Founder, Pitch Interactive
Pitch Interactive
From this contributor
On the same page: Divorce, drawing, and parenting an autistic child
Shared sketch books chart a father-daughter relationship over time and provide a valuable outlet for self-regulating emotions.
On the same page: Divorce, drawing, and parenting an autistic child
By
Rebecca Horne
28 July 2020 | 6 min read
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read